Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids

NCT01635452 is registered in ClinicalTrials.gov with PregLem SA as lead sponsor.

NCT NCT01635452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01635452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids
Lead sponsor
PregLem SA
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2012
Completion date
March 31, 2016
Enrollment
1,500 (estimated)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids